In conclusion, our results demonstrate that OXCT1 epigenetically suppresses antitumor immunity, suggesting that suppressing OXCT1 activity in TAMs is an effective approach for treating liver cancer.
almost 2 years ago
Journal
|
CD8 (cluster of differentiation 8) • OXCT1 (3-Oxoacid CoA-Transferase 1)
Circ-OXCT1 promoted SLC1A5 expression by target binding with miR-516b-5p. Circ-OXCT1 facilitated NSCLC progression via miR-516b-5p-dependent regulation of SLC1A5, which provided a possible circRNA-targeted therapy for NSCLC.
almost 4 years ago
Journal
|
SLC1A5 (Solute Carrier Family 1 Member 5) • OXCT1 (3-Oxoacid CoA-Transferase 1)
Western blot showed that OXCT1-AS1 had no effects on the levels of epithelial-mesenchymal transition biomarkers. Overall, OXCT1-AS1 suppresses miR-886 maturation to promote OS cell proliferation.